肥厚型梗阻性心肌病左室流出道梗阻的外科管理:单中心高容量经验
该回顾性研究分析了2005至2015年间单一术者在高容量肥厚型心肌病中心完成的1559例左室流出道梗阻手术。结果显示室间隔心肌切除术安全有效,院内起搏器植入率低,手术死亡率0.38%,二尖瓣干预对中度肥厚患者是有用辅助。
要点
- 室间隔心肌切除术在高容量中心由经验丰富术者实施安全且结果优异。
- 二尖瓣干预(如瓣叶缩短、腱索切除)可作为中度肥厚患者的辅助手段。
- 孤立性室间隔心肌切除术后无室间隔缺损发生,总体室缺发生率0.13%。
核心结论
- 在高容量专科中心由经验丰富术者实施室间隔心肌切除术安全且结果优异。
- 二尖瓣干预是中度肥厚患者的有用辅助手段。
研究设计与样本
- 回顾性综述2005至2015年连续1559例左室流出道梗阻手术。
- 分析人口学特征、超声心动图心室形态与血流动力学、手术数据和院内结局。
主要发现
- 586例为孤立性室间隔心肌切除术,522例为心肌切除联合二尖瓣或瓣下结构干预,422例为心肌切除联合其他伴随手术,29例为孤立二尖瓣干预无心肌切除。
- 常见二尖瓣干预包括前叶缩短(16%)、腱索切除(9.8%)、乳头肌切除(7.2%)和乳头肌重定向(7.5%)。
- 接受二尖瓣干预者室间隔更薄(18 ± 0.4 mm vs 22 ± 0.5 mm,P < .001)且切除心肌更少(6.2 ± 3.5 g vs 8.8 ± 3.8 g,P < .001)。
- 院内永久起搏器植入率:完全性心脏传导阻滞为4.2%(n = 1334),孤立性室间隔心肌切除且术前传导正常者为1.1%(n = 464)。
临床怎么用
- 对于左室流出道梗阻的肥厚型梗阻性心肌病患者,室间隔心肌切除术应由高容量中心的经验丰富术者实施。
- 对中度肥厚患者,可考虑在心肌切除术中联合二尖瓣干预以优化流出道疏通。
局限性
- 回顾性单中心单术者研究,结果可能受术者经验和中心容量影响,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study evaluates operative approach and contemporary surgical outcomes in the management of left ventricular outflow tract obstruction by a single surgeon at a high-volume, specialized hypertrophic cardiomyopathy center. METHODS: This is a retrospective review of 1559 consecutive operations for left ventricular outflow tract obstruction from 2005 to 2015. Demographic profiles, echocardiogram-derived ventricular morphology and hemodynamics, operative data, and in-hospital outcomes were analyzed. RESULTS: Of the 1559 operations, 586 were isolated septal myectomies, 522 were myectomies with mitral valve or subvalvular apparatus intervention, 422 were myectomies with another concomitant procedure, and 29 were isolated mitral valve interventions without myectomy. Common mitral valve interventions included anterior leaflet shortening (16%), chordae tendineae resection (9.8%), papillary muscle resection (7.2%), and papillary muscle reorientation (7.5%). Ninety-two patients underwent mitral valve replacement, 42 for left ventricular outflow tract obstruction and 50 for intrinsic mitral valve pathology. Patients undergoing mitral interventions had thinner septums (18 ± 0.4 mm vs 22 ± 0.5 mm, P < .001) and less myocardium removed (6.2 ± 3.5 g vs 8.8 ± 3.8 g, P < .001) than patients without a mitral intervention. Prevalence of in-hospital permanent pacemaker insertion was 4.2% (n = 1334) for complete heart block and 1.1% (n = 464) for isolated septal myectomy with normal preoperative conduction. Overall, there were 2 postoperative ventricular septal defects (0.13%) and none for isolated myectomies. Operative mortality was 0.38%. CONCLUSIONS: Septal myectomy can be performed safely with excellent outcomes when the procedure is performed by a highly experienced surgeon in a high-volume, specialized center. A mitral valve intervention is a useful adjunct in patients with moderate hypertrophy.
引用
- Hodges K, Rivas CG, Aguilera J, et al. Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. J Thorac Cardiovasc Surg. 2018. PMID: 30782406. doi:10.1016/j.jtcvs.2018.11.148
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。